SCHEMBL709651

SCHEMBL709651

[CH2]Oc1ccc(Cl)cc1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.49
HTR2A P28223 1/20 0.49
HTR2C P28335 1/20 0.49
HTR2B P41595 1/20 0.49
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2C19 P33261 1/20 0.46
SCN4A P35499 2/20 0.44
SLC6A2 P23975 2/20 0.44
SLC6A4 P31645 2/20 0.44
SLC6A3 Q01959 1/20 0.44
CYP2C9 P11712 1/20 0.42
HIF1A Q16665 1/20 0.42
KDM4E B2RXH2 1/20 0.42
TP53 P04637 1/20 0.42
ALOX15 P16050 1/20 0.42
ALDH1A1 P00352 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
LMNA P02545 2/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL807773 0.81 SLC6A2 (0.59) TSHRHTR2AHTR2CHTR2BCYP1A2
SCHEMBL91412 0.79 TSHR (0.50) TSHRHTR2AHTR2CHTR2BCYP1A2
SCHEMBL10912813 0.77 TSHR (0.49) TSHRHTR2AHTR2CHTR2BCYP1A2
SCHEMBL1021723 0.77 TSHR (0.49) TSHRHTR2AHTR2CHTR2BCYP1A2
SCHEMBL9665251 0.77 SCN4A (0.51) TSHRHTR2AHTR2CHTR2BCYP1A2
SCHEMBL1044925 0.76 ACHE (0.46) TSHRCYP1A2CYP3A4TP53ALDH1A1
SCHEMBL290801 0.76 TTR (0.52) TSHRCYP3A4SLC6A2SLC6A3TP53
SCHEMBL18195113 0.76 TSHR (0.47) TSHRHTR2AHTR2CHTR2BCYP1A2
SCHEMBL8678279 0.76 TSHR (0.47) TSHRHTR2AHTR2CHTR2BCYP1A2
SCHEMBL624403 0.76 TSHR (0.47) TSHRHTR2AHTR2CHTR2BCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124610-B2 Sodium channel inhibitors ICAGEN INC. (US) 2012-02-28 US claimed
EP-2173743-A2 SODIUM CHANNEL INHIBITORS Icagen, Inc. (US) 2010-04-14 EP claimed
US-20090023740-A1 SODIUM CHANNEL INHIBITORS ICAGEN (US) 2009-01-22 US claimed
WO-2009012242-A2 SODIUM CHANNEL INHIBITORS ICAGEN, INC. (US) 2009-01-22 WO claimed
US-4707161-A Lightfastness of dyeings obtained with acid dyes or metal complex dyes on polyamides: treatment with copper hydroxamates BASF AKTIENGESELLSCHAFT (DE) 1987-11-17 US claimed
US-4020061-A 3-Oxomethyl-2-(1-nitro-2-oxoethylidene)-tetrahydro-2H-1,3-thiazines SHELL OIL COMPANY (US) 1977-04-26 US claimed
US-4008249-A HERBICIDE, PLANT GROWTH REGULATOR BASF AKTIENGESELLSCHAFT (DT) 1977-02-15 US claimed
US-8124610-B2 Sodium channel inhibitors ICAGEN INC. (US) 2012-02-28 US disclosed
EP-2173743-A2 SODIUM CHANNEL INHIBITORS Icagen, Inc. (US) 2010-04-14 EP disclosed
US-20090023740-A1 SODIUM CHANNEL INHIBITORS ICAGEN (US) 2009-01-22 US disclosed
WO-2009012242-A2 SODIUM CHANNEL INHIBITORS ICAGEN, INC. (US) 2009-01-22 WO disclosed
EP-0254987-B1 BENZOPHENONE ETHER-ESTERS AND PROCESS FOR IMPROVING THE LIGHT FASTNESS OF POLYESTER COLOURINGS BY THE USE OF BENZOPHENONE ETHER-ESTERS BASF Aktiengesellschaft (DE) 1992-03-04 EP disclosed
EP-0446740-A2 Utilization of benzophenone-derivatives as antiluminous agents for aromatic polycarbonates and polyestercarbonates BASF Aktiengesellschaft (DE) 1991-09-18 EP disclosed
EP-0017132-B1 DYESTUFFS, THEIR PREPARATION AND UTILISATION BASF Aktiengesellschaft (DE) 1981-10-14 EP disclosed
EP-0017132-A1 Dyestuffs, their preparation and utilisation BASF Aktiengesellschaft (DE) 1980-10-15 EP disclosed
US-4138548-A Acaricidal pyridinium salts FISONS LIMITED (GB) 1979-02-06 US disclosed
US-4125617-A Acaricidal pyridinium salts FISONS LIMITED (GB) 1978-11-14 US disclosed
US-4020061-A 3-Oxomethyl-2-(1-nitro-2-oxoethylidene)-tetrahydro-2H-1,3-thiazines SHELL OIL COMPANY (US) 1977-04-26 US disclosed
US-4013669-A ESTER-PYRIDINIUM COMPOUNDS AS ACARICIDES FISONS LIMITED (EN) 1977-03-22 US disclosed
US-4008249-A HERBICIDE, PLANT GROWTH REGULATOR BASF AKTIENGESELLSCHAFT (DT) 1977-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023740-A1 SODIUM CHANNEL INHIBITORS TRPV1, SCN1A, SCN2A TSHR 4445/4885HTR2A 1260/4885HTR2C 852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.